Christine Marie Utter
Svp, Chief Accounting Officer at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 22SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 19,68670,199 held (−22%) | $75.56 | $1.5M | -14.4% |
| Feb 20SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,49470,199 held (−3%) | $69.36 | $173K | -6.7% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,03472,693 held (−1%) | $76.45 | $79K | -15.4% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,38174,962 held (−2%) | $76.95 | $106K | -15.9% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,23573,727 held (−2%) | $77.45 | $96K | -16.5% |
- Sell
Svp, Chief Accounting Officer Christine Marie Utter sold $1.5M of PTCT at $75.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Christine Marie Utter sold $173K of PTCT at $69.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Christine Marie Utter sold $79K of PTCT at $76.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Christine Marie Utter sold $106K of PTCT at $76.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Christine Marie Utter sold $96K of PTCT at $77.45 — pre-scheduled 10b5-1 plan sale.